Medical Advisory Board

The 22 medical advisors we rely upon to guide and review our work are leading authorities on bone marrow failure disease in the U.S. and overseas. Thanks to their excellent oversight, we can be confident that everything we teach and publish represents the latest thinking, research and best practices in the fields of hemotology and oncology.

Position About
Co-Chair

Richard Stone, MD
Dana-Farber Cancer Center

Co-Chair

Mikkael Sekeres, MD, MS
Cleveland Clinic Taussig Cancer Center

Members Pamela Becker, MD, PhD
University of Washington School of Medicine
 

Carlos M. de Castro, III, MD
Duke University Medical Center

  H. Joachim Deeg, MD
Fred Hutchinson Cancer Research Center
 

Amy E. DeZern, MD, MHS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

 

Benjamin L. Ebert, MD, PhD
Dana-Farber/Harvard Cancer Center

 

Guillermo Garcia-Manero, MD
MD Anderson Cancer Center

 

Aristoteles Giagounidis, MD, PhD
Marienhospital - Dusseldorf, Germany

 

Steven D. Gore, MD
Yale School of Medicine

 

Timothy Graubert, MD
Massachusetts General Hospital Cancer Center

 

Alan List, MD
H. Lee Moffitt Cancer Center & Research Institute

  Jaroslaw P. Maciejewski, MD, PhD
Cleveland Clinic Taussig Cancer Center
 

David Margolis, MD
Medical College of Wisconsin

 

Judith Marsh, MD
Kings College Hospital - London, UK

 

Stephen D. Nimer, MD
Sylvester Comprehensive Cancer Center, University of Miami

 

Olatoyosi Odenike, MD
University of Chicago

  Ronald Paquette, MD
UCLA Medical Center
 

Gail J. Roboz, MD
Weill Medical College of Cornell University

  Valeria Santini, M.D.
University of Florence, Florence, Italy
 

B. Douglas Smith, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

 

Neal Young, MD
National Institutes of Health